Can a common supplement slow Alzheimer's? early study tests choline in gene carriers
NCT ID NCT05880849
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 23 times
Summary
This early study tested choline, a dietary supplement, in 15 people aged 55-80 who carry the APOE4 gene, which increases Alzheimer's risk. Researchers checked if choline safely changes fat levels in spinal fluid, aiming to improve fat metabolism. The goal is to see if choline might help control disease progression, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas Health Science Center at Houston (UTHealth)
Houston, Texas, 77054, United States
Conditions
Explore the condition pages connected to this study.